SURE

Chenevas-Paule, Clemence, Wolff, Hans, Ashton, Mark, Schubert, Martin and Dodou, Kalliopi (2017) Development of a Predictive Model for the Stabilizer Concentration Estimation in Microreservoir Transdermal Drug Delivery Systems Using Lipophilic Pressure-Sensitive Adhesives as Matrix/Carrier. Journal of Pharmaceutical Sciences, 106 (5). pp. 1371-1383. ISSN 00223549

Amer, Amer H., Anderson, Rosaleen, Carlile, Mark, Dawson, Peter and Ashton, Mark (2017) A 3D-QSAR Pharmacophore based virtual screening and docking approach to identify novel HIV-1 entry inhibitors. In: New Approaches in Medicinal Chemistry II, 01 Feb 2017, Eli Lilly, Windlesham, UK. (Unpublished)

Chenevas-Paule, Clemence, Wolff, Hans, Ashton, Mark, Schubert, Martin and Dodou, Kalliopi (2017) Development of a predictive model for the long term stability assessment of drug-in-adhesive transdermal films using polar pressure sensitive adhesives as carrier/matrix. Journal of Pharmaceutical Sciences, 106 (5). pp. 1293-1301. ISSN 0022-3549

McGarry, Kenneth, Emery, Kirsty, Varnakulasingam, Vithusa, McDonald, Sharon and Ashton, Mark (2016) Complex network based computational techniques for edgetic modelling of mutations implicated with human diseases. In: 16th UK Workshop on Computational Intelligence, UKCI-2016, 7-9 Sep 2016, Lancaster University.

Wong, Rachel, Ashton, Mark and Dodou, Kalliopi (2016) Analysis of residual crosslinking agent content in UV cross-linked poly(ethylene oxide) hydrogels for dermatological application, by gas chromatography. Journal of Pharmaceutical Analysis, 6 (5). pp. 307-302. ISSN 2095-1779

Hann, Victoria, Dawson, Peter and Ashton, Mark (2016) Allosteric Integrase Inhibitors. In: Frontiers in Clinical Drug Research-HIV. Bentham Science Publishers, UAE, pp. 49-126. ISBN 9781681082301

Wong, Rachel, Ashton, Mark and Dodou, Kalliopi (2015) Effect of Crosslinking Agent Concentration on the Properties of Unmedicated Hydrogels. Pharmaceutics, 7 (3). pp. 305-319. ISSN 1999-4923

Wong, Rachel, Ashton, Mark, Wolff, Hans and Dodou, Kalliopi (2015) Effect of Photoinitiator Concentration on the Properties of Unmedicated Hydrogels. In: 42nd Annual Meeting & Exposition of the Controlled Release Society, 26-29 Jul 2015, Edinburgh, Scotland. (Submitted)

Hann, Victoria and Ashton, Mark (2015) HIV Integrase - Biology and Inhibitor Design. In: Frontiers in Clinical Drug Research - HIV. Bentham Science Publishers, pp. 185-286. ISBN 978-1-60805-897-6

Chenevas-Paule, Clemence, Ashton, Mark, Wolff, Hans Michael and Dodou, Kalliopi (2014) Studies on the interaction of poly(vinylpyrrolidone) with ibuprofen, salicylic acid and aspirin. In: APS PharmSci2014: The Science of Medicines, 8-10 Sep 2014, University of Hertfordshire, Hatfied. (Unpublished)

Ashton, Mark and Medhi, Manjul (2011) Current pharmacological treatments and research and development in HIV. The Pharmaceutical Journal, 286. pp. 695-696. ISSN 0031-6873

Ashton, Mark and Crockatt, Kay (2011) Current therapies and research and development in the treatment of asthma. The Pharmaceutical Journal, 286. pp. 569-570. ISSN 0031-6873

Sherwood, John, Ashton, Mark, Newton, Clare and Biles, Sumita (2011) Current and future options for the management of heart failure. The Pharmaceutical Journal, 286. pp. 437-438. ISSN 0031-6873

WO2011039528 (2011) 2-PYRIDONE COMPOUNDS USED AS INHIBITORS OF NEUTROPHIL ELASTASE. WO2011039528.

Ashton, Mark and Todd, Adam (2011) Current research and development of new treatments for schizophrenia. The Pharmaceutical Journal, 286. pp. 174-175. ISSN 0031-6873

Marth, Gabriella, Anderson, Rosaleen, Thompson, Barry G, Ashton, Mark and Groundwater, Paul (2010) Chemo- and regioselectivity in the reactions of polyfunctional pyrroles. Tetrahedron, 66 (32). pp. 6113-6120. ISSN 0040-4020

Todd, Adam, Moore, Adrian, Ashton, Mark and Van, Son (2010) Current research and development of treatments for Alzheimer’s disease. The Pharmaceutical Journal, 284 (7599). pp. 429-430. ISSN 0031-6873